Connectus Wealth’s Gilead Sciences GILD Stock Holding History

Connectus Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3.08M	Buy	41,911 +1,706	+4%	+$131K	0.08%	150
2023 Q4	$3.26M	Sell	40,205 -640	-2%	-$49.8K	0.07%	205
2023 Q3	$3.07M	Buy	40,845 +6,541	+19%	+$503K	0.07%	213
2023 Q2	$2.65M	Buy	34,304 +692	+2%	+$55.2K	0.06%	192
2023 Q1	$2.79M	Buy	33,612 +2,574	+8%	+$213K	0.07%	195
2022 Q4	$2.67M	Buy	31,038 +9,746	+46%	+$772K	0.06%	189
2022 Q3	$1.32M	Buy	21,292 +645	+3%	+$40.7K	0.03%	303
2022 Q2	$1.28M	Buy	20,647 +15,647	+313%	+$969K	0.03%	243
2022 Q1	$363K	Sell	5,000 -284	-5%	-$18.2K	0.01%	320
2021 Q4	$384K	Buy	+5,284	New	+$364K	0.01%	284

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connectus Wealth's GILD Position: Q1 2024 in Review

Connectus Wealth increased its Gilead Sciences (GILD) stake by 4.2% in Q1 2024, buying an estimated $131K and bringing the position to 41,911 shares worth $3.08M. The position accounts for 0.08% of the portfolio, ranked #150.

Connectus Wealth first reported a position in GILD in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.26M in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Connectus Wealth held 41,911 shares of Gilead Sciences worth $3.08M as of Q1 2024.
Connectus Wealth bought 1,706 Gilead Sciences shares in Q1 2024, an estimated $131K.
Gilead Sciences made up 0.08% of Connectus Wealth's portfolio in Q1 2024, its #150 holding.
Connectus Wealth first reported a position in Gilead Sciences in Q4 2021 and has held it in 10 quarters since.
Connectus Wealth's Gilead Sciences position peaked at $3.26M in Q4 2023.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.